New research published by MarketsandMarkets on Glycomics Market has provided a qualitative and quantitative evaluation of various market attributes and elements including market definition, dynamics, research methodology, segments, and competitive landscape. In addition to providing insights into the current state of the market, the report also details the plans for the future growth and expansion of the market.
The global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% from 2020 to 2025.
Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
The enzymes segment accounted for the largest share of the glycomics market, by product, in 2019
The glycomics market, by enzymes, has been categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of RD and drug discovery procedures.
Glycomics market for drug discovery development application is expected to grow at a high rate
By application, the glycomics market is segmented into drug discovery development, disease diagnostics, and other applications. Drug discovery development is the largest and the fastest-growing application segment in the glycomics market, majorly due to the increasing RD investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
North America is the largest regional market for glycomics products
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global glycomics market, followed by Europe. The largest share of North America is mainly attributed to increasing funding on glycomics research, rising RD expenditure for drug discovery development, and the presence of all key players.
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).
Make an Enquire to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=132685525
Don’t miss out on business opportunities in Glycomics / Glycobiology Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
